Skip to main content
Adaptive Biotechnologies Corp logo

Adaptive Biotechnologies Corp — Investor Relations & Filings

Ticker · ADPT ISIN · US00650F1093 LEI · 549300ZTF7OT1FW66Q96 US Professional, scientific and technical activities
Filings indexed 695 across all filing types
Latest filing 2026-04-24 Annual Report
Country US United States of America
Listing US ADPT

About Adaptive Biotechnologies Corp

https://www.adaptivebiotech.com

Adaptive Biotechnologies Corp. is a commercial-stage company focused on immune-driven medicine. It specializes in decoding the adaptive immune system to develop clinical products for diagnosing and treating diseases. The company operates an Immune Medicine Platform that sequences T-cell and B-cell receptors to generate immune receptor data. This data is applied across life sciences research, clinical diagnostics, and drug discovery. A key offering is clonoSEQ, a highly sensitive, next-generation sequencing (NGS) assay for assessing Minimal Residual Disease (MRD) in certain blood cancers. This product is utilized in both clinical practice and biopharmaceutical drug trials. The company aims to harness the immune system's natural capabilities as a tool to transform disease detection and treatment.

Recent filings

Filing Released Lang Actions
ARS - Adaptive Biotechnologies Corp (0001478320) (Filer)
Annual Report
2026-04-24 English
4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
Director's Dealing
2026-03-27 English
SCHEDULE 13G/A - Adaptive Biotechnologies Corp (0001478320) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
Director's Dealing
2026-03-24 English
4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)
Director's Dealing
2026-03-18 English
4 - ADAPTIVE BIOTECHNOLOGIES CORP (0001478320) (Filer)
Director's Dealing
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.